Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML, Clinical Trials

Jessica Altman

MD

🏢Northwestern University Feinberg School of Medicine🌐USA

Professor of Medicine

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jessica Altman at Northwestern is an AML specialist and clinical trialist who has contributed to SWOG and other cooperative group AML trials. Her research on gemtuzumab ozogamicin optimization, novel targeted agents in AML, and AML in special populations has contributed to the evidence base for this disease. She has also contributed to understanding patient-reported outcomes and quality of life in AML treatment.

Share:

🧪Research Fields 研究领域

AML
gemtuzumab ozogamicin
ALFA-0701
antibody-drug conjugates AML
cooperative group AML trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Jessica Altman 的研究动态

Follow Jessica Altman's research updates

留下邮箱,当我们发布与 Jessica Altman(Northwestern University Feinberg School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment